Designing an effective antibody drug is like searching for the right key in a warehouse of locks. Scientists may begin with ...

Immunizations against measles, mumps and rubella aren’t available as stand-alone shots. What’s more, experts say there’s no evidence to support breaking up the vaccine into three.

President Trump's new executive order on vaccines raises a number of public health concerns. A physician breaks those down.

FDA Approval of Replimune's Intratumoral Therapy in Combination With Checkpoint Inhibition Reinforces Growing Momentum Behind ...

Stand Up To Cancer® (SU2C) today announced the recipients of the SU2C Nina Nicolai Pancreatic Cancer Innovation in Collaboration Award. The approximately $225,000 in award funding will support a multi ...

Cemsidomide’s Ongoing Phase 2 MOMENTUM Trial and Phase 1b Trial in Combination With Elranatamab Remain on Track to Deliver Clinical Data Readouts in 2027 ...

Trump signed an executive order directing federal health agencies to revise childhood vaccine recommendations and specifically calling for combination vaccines to be separated ...

Replimune Group, Inc. (Nasdaq: REPL) ('Replimune”), a commercial-stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced the pricing of an ...

Broad label to address high unmet need in advanced melanomaReplimune will host conference call on August 6, 2026 at 4:30 p.m. ET. WOBURN, ...

Vir Biotechnology, Inc. (Nasdaq: VIR), today provided a corporate update and reported financial results for the second quarter ended June 30, 2026.

The race to save a South Florida woman is on. OneBlood is calling on those of African descent to donate blood as soon as they can to save the life of 18-year-old Gigi Felix, who has sickle cell ...

Winston & Strawn and Taylor Wessing's U.K.-led business have officially launched as Winston Taylor, a transatlantic law firm with more than 1,400 lawyers and estimated annual revenues of approximately ...